Congratulations to Dean Mangione and Dr. Zito

Dear Readers,

The Rho Chi Post Editorial Board wishes Dr. Robert A. Mangione and Dr. S. William Zito our warmest congratulations on their recent appointments as Interim Provost and Interim Dean of St. John’s University’s College of Pharmacy and Health Sciences, respectively.

Dr. Mangione, affectionately known as Dean Mangione by students, is a well-respected and beloved faculty member who will now be the face of St. John’s University.  Dr. Zito, the driving force behind the Rho Chi Post, is both an advocate and mentor for numerous students through the Rho Chi Beta Delta Chapter and his research laboratory.  Their new roles speak volumes of their character and it is a great credit to the College of Pharmacy and Health Sciences to have such dedicated faculty members.

These promotions follow the decision of St. John’s University’s current Provost, Dr. Julia Upton, to step down as provost to continue her role as a well-distinguished Professor of Theology.  Dr. Upton will also hold the title of Special Assistant to the President, Rev. Harrington.  Dr. Mangione and Dr. Zito are expected to hold their new positions until such a time when the Provost Search Committee, headed by Dr. Michael A. Simons (Dean of the School of Law), completes their search for a new candidate for the office of Provost.

It is our pleasure, as editors of the Rho Chi Post, to recognize the continuing outstanding achievements of Dr. Mangione and Dr. Zito to the university community.  We thank them for their continued support of our newsletter and wish them the best in their new positions.

Sincerely,

The Editorial Board

eMAR

Recent Posts

Oxidative Stress and Its Impact on Vitiligo

By: Zurriya Faran, PharmD Candidate c/o 2031 The visible loss of skin pigmentation often indicates…

2 months ago

Thiamine Metabolic Dysfunction Syndrome: Overview, importance, MOA, and treatment

By: Archana Murugan, PharmD candidate c/o 2029 Overview             Thiamine metabolic dysfunction syndrome (TMDS) refers…

2 months ago

Updated Guidelines for the Treatment of Multidrug and Rifampin-Resistant TB and Promising New Anti-TB Drugs in Phase 2/3 Trials

By: Kevin Lee, PharmD Candidate c/o 2028, Angela Yin, PharmD Candidate c/o 2028             The…

2 months ago

Sixth Year Perspective: Interview with Ariella Zadrima, PharmD Candidate, c/o 2026

By: Aymon Choudhury, PharmD Candidate c/o 2027 APPE questions: How did your APPE rotations shape…

2 months ago

Foundayo: The New Drug in the GLP-1 market

By: Sariah Grant, PharmD Candidate c/o 2027             The rise of glucagon-like peptide -1 receptor…

2 months ago

Should All Drugs be OTC? Risks and Consequences of the FDA Commissioner Statement

By: Amanda Kastel, PharmD Candidate c/o 2027 In February 2026, FDA Commissioner Marty Makary stated…

2 months ago